UroGen Pharma 2026年第二季度业绩预告 (NASDAQ:URGN)
· seekingalpha.com
UroGen Pharma (URGN) 预定于8月5日周三开盘前公布第二季度财务业绩。市场共识的每股收益 (EPS) 预期为 -$0.27 (同比增长 74.3%)。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...